BeiGene Ltd (BGNE)
133.84
-4.66
(-3.36%)
USD |
NASDAQ |
Apr 16, 16:00
133.84
0.00 (0.00%)
After-Hours: 17:35
BeiGene Shareholders Equity (Quarterly): 3.537B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.537B |
| September 30, 2023 | 3.763B |
| June 30, 2023 | 3.799B |
| March 31, 2023 | 4.157B |
| December 31, 2022 | 4.383B |
| September 30, 2022 | 4.655B |
| June 30, 2022 | 5.303B |
| March 31, 2022 | 5.886B |
| December 31, 2021 | 6.133B |
| September 30, 2021 | 3.357B |
| June 30, 2021 | 3.607B |
| March 31, 2021 | 4.004B |
| December 31, 2020 | 3.869B |
| September 30, 2020 | 4.287B |
| June 30, 2020 | 2.536B |
| March 31, 2020 | 2.812B |
| December 31, 2019 | 962.20M |
| September 30, 2019 | 1.278B |
| Date | Value |
|---|---|
| June 30, 2019 | 1.554B |
| March 31, 2019 | 1.609B |
| December 31, 2018 | 1.739B |
| September 30, 2018 | 1.970B |
| June 30, 2018 | 1.213B |
| March 31, 2018 | 1.344B |
| December 31, 2017 | 669.81M |
| September 30, 2017 | 750.14M |
| June 30, 2017 | 255.75M |
| March 31, 2017 | 308.42M |
| December 31, 2016 | 352.91M |
| September 30, 2016 | 187.83M |
| June 30, 2016 | 220.05M |
| March 31, 2016 | 243.10M |
| December 31, 2015 | 74.32M |
| September 30, 2015 | 100.08M |
| June 30, 2015 | 109.91M |
| December 31, 2014 | 25.77M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
962.20M
Minimum
Dec 2019
6.133B
Maximum
Dec 2021
3.678B
Average
3.799B
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
| Theravance Biopharma Inc | 213.00M |
| LumiraDx Ltd | -213.83M |
| ASLAN Pharmaceuticals Ltd | -0.8817M |
| Zai Lab Ltd | 796.12M |
| Legend Biotech Corp | 1.251B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.805B |
| Total Liabilities (Quarterly) | 2.268B |
| Debt to Equity Ratio | 0.2505 |
| Current Ratio | 2.322 |
| Net Debt Paydown Yield | -0.25% |